279 related articles for article (PubMed ID: 32151238)
1. Effects of miR-199a on autophagy by targeting glycogen synthase kinase 3β to activate PTEN/AKT/mTOR signaling in an MPP
Ba RQ; Liu J; Fan XJ; Jin GL; Huang BG; Liu MW; Yang JS
Neurol Res; 2020 Apr; 42(4):308-318. PubMed ID: 32151238
[No Abstract] [Full Text] [Related]
2. MiR-181b regulates autophagy in a model of Parkinson's disease by targeting the PTEN/Akt/mTOR signaling pathway.
Li W; Jiang Y; Wang Y; Yang S; Bi X; Pan X; Ma A; Li W
Neurosci Lett; 2018 May; 675():83-88. PubMed ID: 29608948
[TBL] [Abstract][Full Text] [Related]
3. MiR-410 exerts neuroprotective effects in a cellular model of Parkinson's disease induced by 6-hydroxydopamine via inhibiting the PTEN/AKT/mTOR signaling pathway.
Ge H; Yan Z; Zhu H; Zhao H
Exp Mol Pathol; 2019 Aug; 109():16-24. PubMed ID: 31067440
[TBL] [Abstract][Full Text] [Related]
4. SNHG1 promotes MPP
Zhao J; Geng L; Chen Y; Wu C
Biol Res; 2020 Jan; 53(1):1. PubMed ID: 31907031
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of NogoA prevents MPP+‑induced neurotoxicity in PC12 cells via the mTOR/STAT3 signaling pathway.
Zhong J; Li X; Wan L; Chen Z; Zhong S; Xiao S; Yan Z
Mol Med Rep; 2016 Feb; 13(2):1427-33. PubMed ID: 26648565
[TBL] [Abstract][Full Text] [Related]
6. Apelin-36 exerts the cytoprotective effect against MPP
Zhu J; Dou S; Jiang Y; Bai B; Chen J; Wang C; Cheng B
Life Sci; 2019 May; 224():95-108. PubMed ID: 30905782
[TBL] [Abstract][Full Text] [Related]
7. SOS1-IT1 silencing alleviates MPP
Fan J; Wu D; Guo Y; Yang Z
J Clin Neurosci; 2022 May; 99():137-146. PubMed ID: 35279586
[TBL] [Abstract][Full Text] [Related]
8. miR-155 Affects Osteosarcoma MG-63 Cell Autophagy Induced by Adriamycin Through Regulating PTEN-PI3K/AKT/mTOR Signaling Pathway.
Wang L; Tang B; Han H; Mao D; Chen J; Zeng Y; Xiong M
Cancer Biother Radiopharm; 2018 Feb; 33(1):32-38. PubMed ID: 29412697
[TBL] [Abstract][Full Text] [Related]
9. miR-29a promotes pathological cardiac hypertrophy by targeting the PTEN/AKT/mTOR signalling pathway and suppressing autophagy.
Shi JY; Chen C; Xu X; Lu Q
Acta Physiol (Oxf); 2019 Oct; 227(2):e13323. PubMed ID: 31162869
[TBL] [Abstract][Full Text] [Related]
10. MiR-212-3p improves rat functional recovery and inhibits neurocyte apoptosis in spinal cord injury models via PTEN downregulation-mediated activation of AKT/mTOR pathway.
Guan C; Luan L; Li J; Yang L
Brain Res; 2021 Oct; 1768():147576. PubMed ID: 34216580
[TBL] [Abstract][Full Text] [Related]
11. MiR-93-5p targeting PTEN regulates the NMDA-induced autophagy of retinal ganglion cells via AKT/mTOR pathway in glaucoma.
Li R; Jin Y; Li Q; Sun X; Zhu H; Cui H
Biomed Pharmacother; 2018 Apr; 100():1-7. PubMed ID: 29421576
[TBL] [Abstract][Full Text] [Related]
12. Tumor suppressive activity of miR-424-5p in breast cancer cells through targeting PD-L1 and modulating PTEN/PI3K/AKT/mTOR signaling pathway.
Dastmalchi N; Hosseinpourfeizi MA; Khojasteh SMB; Baradaran B; Safaralizadeh R
Life Sci; 2020 Oct; 259():118239. PubMed ID: 32784058
[TBL] [Abstract][Full Text] [Related]
13. Galangin decreases p‑tau, Aβ42 and β‑secretase levels, and suppresses autophagy in okadaic acid‑induced PC12 cells via an Akt/GSK3β/mTOR signaling‑dependent mechanism.
Huang L; Lin M; Zhong X; Yang H; Deng M
Mol Med Rep; 2019 Mar; 19(3):1767-1774. PubMed ID: 30628698
[TBL] [Abstract][Full Text] [Related]
14. miR-199a impairs autophagy and induces cardiac hypertrophy through mTOR activation.
Li Z; Song Y; Liu L; Hou N; An X; Zhan D; Li Y; Zhou L; Li P; Yu L; Xia J; Zhang Y; Wang J; Yang X
Cell Death Differ; 2017 Jul; 24(7):1205-1213. PubMed ID: 26160071
[TBL] [Abstract][Full Text] [Related]
15. MiR-146b inhibits autophagy in prostate cancer by targeting the PTEN/Akt/mTOR signaling pathway.
Gao S; Zhao Z; Wu R; Wu L; Tian X; Zhang Z
Aging (Albany NY); 2018 Aug; 10(8):2113-2121. PubMed ID: 30153654
[TBL] [Abstract][Full Text] [Related]
16. Effects of miR-21 on hypertensive rats through PTEN/PI3K/Akt/mTOR signaling pathway.
Shi YJ; Xu W; Han YF; Li JX; Niu LL; Chen YD
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4924-4931. PubMed ID: 31210327
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA HAGLROS regulates apoptosis and autophagy in Parkinson's disease via regulating miR-100/ATG10 axis and PI3K/Akt/mTOR pathway activation.
Peng T; Liu X; Wang J; Liu Y; Fu Z; Ma X; Li J; Sun G; Ji Y; Lu J; Wan W; Lu H
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2764-2774. PubMed ID: 31298038
[TBL] [Abstract][Full Text] [Related]
18. LncRNA NEAT1 promotes MPP+ induced injury of PC12 cells and accelerates the progression of Parkinson's disease in mice through FUS mediated inhibition of PI3K/AKT/mTOR signalling pathway.
Wang Y; Li Z; Li J; Sun C
Exp Gerontol; 2024 Jun; 191():112436. PubMed ID: 38636570
[TBL] [Abstract][Full Text] [Related]
19. MiR-133b inhibits MPP+-induced apoptosis in Parkinson's disease model by inhibiting the ERK1/2 signaling pathway.
Dong LG; Lu FF; Zu J; Zhang W; Xu CY; Jin GL; Yang XX; Xiao QH; Cui CC; Xu R; Zhou S; Zhu JN; Shen T; Cui GY
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11192-11198. PubMed ID: 33215437
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-29a contributes to drug-resistance of breast cancer cells to adriamycin through PTEN/AKT/GSK3β signaling pathway.
Shen H; Li L; Yang S; Wang D; Zhong S; Zhao J; Tang J
Gene; 2016 Nov; 593(1):84-90. PubMed ID: 27523474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
